COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 2295: Articles 22941-22950  | Next

Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
Mastellos, D. C., Pires da Silva, B. G. P., Fonseca, B. A. L., Fonseca, N. P., Martins, M. A., Mastaglio, S., Ruggeri, A., Sironi, M., Radermacher, P., Skendros, P., Ritis, K., Manfra, I., Iacobelli, S., Huber-Lang, M., Nilsson, B., Yancopoulou, D., Connolly, E. S., Garlanda, C., Ciceri, F., Risitano, A. M., Calado, R. T., Lambris, J. D.
10.1101/2020.08.17.20174474 — Posted: 2020-08-21
What if we perceive SARS-CoV-2 genomes as documents? Topic modelling using Latent Dirichlet Allocation to identify mutation signatures and classify SARS-CoV-2 genomes
Nagpal, S., Srivastava, D., Mande, S. S.
10.1101/2020.08.20.258772 — Posted: 2020-08-20
Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection
Freuling, C. M., Breithaupt, A., Mueller, T., Sehl, J., Balkema-Buschmann, A., Rissmann, M., Klein, A., Wylezich, C., Hoeper, D., Wernike, K., Aebischer, A., Hoffmann, D., Friedrichs, V., Dorhoi, A., Groschup, M., Beer, M., Mettenleiter, T. C.
10.1101/2020.08.19.256800 — Posted: 2020-08-20 Discussion: Offsite
A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD
Han, X., Wang, Y., Li, S., Tang, N., Hu, C., Li, T., Xie, Y., Shen, M., Wang, J., Gu, C., Hu, J., Gong, F., Wu, R., Gao, F., Huang, J., Mu, S., Luo, F., Long, Y., Song, S., Long, S., Hao, Y., Chen, Q., Li, L., Wu, Y., Xu, W., Cai, X., Gao, Q., Zhang, G., He, C., Wang, K., Deng, K., Du, L., Nai, Y., Wang, W., Huang, A., Jin, A.
10.1101/2020.08.19.253369 — Posted: 2020-08-20
SARS-CoV-2 Quasispecies provides insight into its genetic dynamics during infection
Sun, F., Wang, X., Tan, S., Dan, Y., Lu, Y., Zhang, J., Xu, J., Tan, Z., Xiang, X., Zhou, Y., He, W., Wan, X., Zhang, W., Chen, Y., Tan, W., Deng, G.
10.1101/2020.08.20.258376 — Posted: 2020-08-20
SARS-CoV-2 infection dynamics in lungs of African green monkeys
Speranza, E., Williamson, B. N., Feldmann, F., Sturdevant, G. L., Perez-Perez, L., Mead-White, K., Smith, B. J., Lovaglio, J., Martens, C., Munster, V., Okumura, A., Shaia, C., Feldmann, H., Best, S. M., de Wit, E.
10.1101/2020.08.20.258087 — Posted: 2020-08-20
Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
Gorshkov, K., Chen, C. Z., de la Torre, J. C., Martinez-Sobrido, L. Z., Moran, T., Zheng, W.
10.1101/2020.08.20.258129 — Posted: 2020-08-20
An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2
Cheng, z., Zhang, D., Liu, X., Miao, J., wang, J., Guo, H., Yan, W., Zhang, Z., Lu, S., Zhang, N., Wang, J., Zhang, Z., Liu, W., Zhang, Y., Zhang, L., Dong, J., Lemoine, N. R., Wang, Y.
10.1101/2020.08.19.258244 — Posted: 2020-08-20
A Human-Immune-System mouse model for COVID-19 research(DRAGA mouse: HLA-A2.HLA-DR4.Rag1KO.IL-2Rγc KO.NOD)
Brumeanu, T.-D., Vir, P., Shashikumar, S., Karim, A. F., Kar, S., Chung, K. K., Pratt, K. P., Casares, S. A.
10.1101/2020.08.19.251249 — Posted: 2020-08-20
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
Parker, R., Partridge, T., Wormald, C., Kawahara, R., Stalls, V., Aggelakopoulou, M., Parker, J., Powell Doherty, R., Ariosa-Morejon, Y., Lee, E., Saunders, K., Haynes, B. F., Acharya, P., Thaysen-Andersen, M., Borrow, P., Ternette, N.
10.1101/2020.08.19.255901 — Posted: 2020-08-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).